Screener
BioCryst Pharmaceuticals BCRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's current ratio?
- BioCryst Pharmaceuticals (BCRX) reported current ratio of 2.3× in Q2 2026.
- How has BioCryst Pharmaceuticals's current ratio changed year-over-year?
- BioCryst Pharmaceuticals's current ratio increased by 3.2% year-over-year, from 2.2× to 2.3×.
- What is the long-term trend for BioCryst Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's current ratio has grown at a -7.6% compound annual growth rate (CAGR), from 3.1× to 2.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about BioCryst Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude